Author: Chih Wei Teng

Woman lying in hospital bed. Image credit: Sharon McCutcheon on Unsplash

Adding CAR-T to Cart: What are the hurdles impacting patient access to cell and gene therapies?

Chih Wei Teng | August 21, 2019

Innovative and curative treatments continually push the boundaries of treating known medical conditions. However, as the world changes gears, shifting from small molecules to cellular and gene therapies,

Sky reflected in corner of a glass skyscraper

News

A reflection of the 11th Business of Regenerative Medicine

Chih Wei Teng | October 22, 2018

It was a sunny Philadelphia that greeted the 11th Business of Regenerative Medicine Symposium. Hosted at the University of Pennsylvania’s Similow Center for Translational Research, the two-day symposium

CCRM_au

@CCRM_au

Congratulations to @cynatastemcells on signing Fujifilm to commercialise Cynata Therapeutics's GvHD therapy! Read the ASX Announcement via the tweet below. twitter.com/cynatastemcell…

12:04 am · September 20, 2019

CCRM_au

@CCRM_au

The #SummerByDesign program provides an opportunity for PhD students & ECRs to learn about the commercialisation of #regenmed in a hyper-accelerated workshop. We are proud to be involved in this program through @CCRM_ca. twitter.com/CCRM_ca/status…

11:02 pm · September 18, 2019

CCRM_au

@CCRM_au

ICYMI: The latest edition of our newsletter is now available and can be accessed via 👉 bit.ly/32QrZah. Sign up to ensure you never miss an edition. #regenmed #commercialization @CCRM_ca pic.twitter.com/iw2KTJICgD

8:35 am · September 18, 2019

CCRM_au

@CCRM_au

Congratulations 👏 to @BecLeeSteere from @Hudson_Research on being the recipient of the '40 Under 40: Most Influential Asian-Australian' award for her contribution to science & medicine. Associate Prof Rebecca Lim is a valued member of our Scientific Advisory Board at @CCRM_au. twitter.com/Hudson_Researc…

12:39 am · September 17, 2019

CCRM_au

@CCRM_au

In our latest blog, featuring @CellTherapies_, we explore the role sensors might play in addressing future challenges faced by #celltherapies that will reach the market in the next five years & beyond. #regenmed #commercialization bit.ly/3029Pp1

8:35 am · September 16, 2019

CCRM_au

@CCRM_au

CCRM Australia is proud to announce that we have partnered with @NSWStemCellNet who work to raise awareness of #stemcell technology, research & potential therapeutic application. PING @MTPConnect_AUS pic.twitter.com/rlykFzCrn2

8:30 pm · September 15, 2019

CCRM_au

@CCRM_au

We've been helping ECR's & PhD students to gain the skills needed to commercialise & translate their #regenmed research into thriving business ventures. This yr we sent PhD candidate Jason Limnios from @BondUniversity to attend @MbD_UofT #SummerbyDesign. bit.ly/2LtkaS8

9:45 am · September 12, 2019

CCRM_au

@CCRM_au

When assembling conference & event pannels, there is no longer an excuse for being unable to source female experts to create a gender-balanced panel. This is a great resource to search for female researchers. twitter.com/CSIRO/status/1…

5:51 am · September 12, 2019

CCRM_au

@CCRM_au

Did you know that we have a newsletter? Subscribe via bit.ly/2ZPxQyL to get the latest #regenmed & CCRM news PING @MTPConnect_AUS @AusBiotech @VicGovAu @GregHuntMP @StemCellsAus @AusStemCell @CCRM_ca pic.twitter.com/Oae4w28J0r

9:35 am · September 9, 2019

CCRM_au

@CCRM_au

The barriers impacting patient access to #celltherapies & #genetherapies in Aus are complex & involve difficulty enrolling in international #clinicaltrials /lack of a local site; $ of treatments to patients; & lack of infrastructure & reimbursement schemes.bit.ly/2zsCJ1N pic.twitter.com/RgdFkCwgTo

10:00 am · August 29, 2019